ÀçÁ¶ÇÕ ¼¼Æ÷¹è¾ç º¸ÃæÁ¦ ½ÃÀå : À¯Çüº°, ¿ëµµº°, ÃÖÁ¾»ç¿ëÀÚº°, ±¹°¡º°, Áö¿ªº° - »ê¾÷ ºÐ¼®, ½ÃÀå ±Ô¸ð, ½ÃÀå Á¡À¯À², ¿¹Ãø(2024-2032³â)
Recombinant Cell Culture Supplements Market, By Type, By Application, By End User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032
»ùÇà ¿äû ¸ñ·Ï¿¡ Ãß°¡
º¸°í¼ ÇÏÀ̶óÀÌÆ®
ÀçÁ¶ÇÕ ¼¼Æ÷¹è¾ç º¸ÃæÁ¦ ½ÃÀå ±Ô¸ð´Â 2023³â 27¾ï 232¸¸ ´Þ·¯·Î 2024³âºÎÅÍ 2032³â±îÁö CAGR 7.39%·Î È®´ëµÉ °Í
ÀçÁ¶ÇÕ ¼¼Æ÷¹è¾ç º¸ÃæÁ¦ ½ÃÀå - ½ÃÀå ¿ªÇÐ
¹ÙÀÌ¿ÀÀǾàǰ ¹× Áٱ⼼Æ÷ Ä¡·á ¿¬±¸ ¼ö¿ä È®´ë°¡ ½ÃÀå ¼ö¿ä¸¦ ÃËÁøÇÒ °ÍÀ¸·Î Àü¸Á
¹ÙÀÌ¿ÀÀǾàǰ ºÎ¹®Àº ´ÜŬ·ÐÇ×ü, ¹é½Å, ¼¼Æ÷ Ä¡·áÁ¦ µî »ý¹°ÇÐÀû Á¦Á¦ °³¹ß¿¡ ÈûÀÔ¾î Áö¼ÓÀûÀ¸·Î ¼ºÀåÇϰí ÀÖ½À´Ï´Ù. ÀçÁ¶ÇÕ ¼¼Æ÷¹è¾ç º¸ÃæÁ¦´Â ´ë±Ô¸ð ¼¼Æ÷¹è¾ç ½Ã½ºÅÛ¿¡¼ ÀÌ·¯ÇÑ »ý¹°ÇÐÀû Á¦Á¦¸¦ »ý»êÇÏ´Â µ¥ ÇʼöÀûÀÔ´Ï´Ù. µû¶ó¼ ¹ÙÀÌ¿À Á¦¾à »ê¾÷¿¡¼ ¼¼Æ÷¹è¾ç º¸ÃæÁ¦¿¡ ´ëÇÑ ³ôÀº ¼ö¿ä°¡ ½ÃÀå ¼ºÀåÀ» ÃËÁøÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. °ü·ù ½Ã½ºÅÛ, ÀÏȸ¿ë ¹ÙÀÌ¿À¸®¾×ÅÍ, ¸¶ÀÌÅ©·Îij¸®¾î ±â¹Ý ¹è¾ç°ú °°Àº ¼¼Æ÷¹è¾ç ±â¼úÀÇ Çõ½ÅÀº ¼¼Æ÷ÀÇ Áõ½Ä°ú »ý»ê¼ºÀ» ÃÖÀûÈÇϱâ À§ÇØ ÀçÁ¶ÇÕ º¸ÃæÁ¦¸¦ Á¤È®ÇÏ°Ô ¹èÇÕÇÑ Æ¯¼ö ¹èÁö Á¦Á¦¸¦ ÇÊ¿ä·Î ÇÕ´Ï´Ù.
¶ÇÇÑ, Àç»ýÀÇ·á ¹× Áٱ⼼Æ÷ Ä¡·á ºÐ¾ß´Â ºü¸£°Ô ¼ºÀåÇϰí ÀÖÀ¸¸ç, Áٱ⼼Æ÷ÀÇ Áõ½Ä°ú ºÐȸ¦ Áö¿øÇϴ ÷´Ü ¼¼Æ÷¹è¾ç ½Ã½ºÅÛ¿¡ ´ëÇÑ ¼ö¿ä¸¦ ÁÖµµÇϰí ÀÖ½À´Ï´Ù. ÀçÁ¶ÇÕ º¸ÃæÁ¦´Â ÀÌ·¯ÇÑ ºÐ¾ß¿¡ ÇÊ¿äÇÑ ¼ºÀåÀÎÀÚ¿Í »çÀÌÅäÄ«ÀÎÀ» °ø±ÞÇÏ´Â µ¥ Áß¿äÇÑ ¿ªÇÒÀ» Çϰí ÀÖ½À´Ï´Ù. ¾Ï, ´ç´¢º´, ÀÚ°¡¸é¿ªÁúȯ°ú °°Àº ¸¸¼ºÁúȯÀÇ À¯º´·üÀº Àü ¼¼°èÀûÀ¸·Î Áõ°¡Çϰí ÀÖÀ¸¸ç, Á¦¾àȸ»çµéÀº »õ·Î¿î Ä¡·á¹ýÀ» °³¹ßÇϱâ À§ÇØ ³ë·ÂÇϰí ÀÖ½À´Ï´Ù. ÀçÁ¶ÇÕ ¼¼Æ÷¹è¾ç º¸ÃæÁ¦´Â ÀÌ·¯ÇÑ Ä¡·á¿¡ »ç¿ëµÇ´Â »ý¹°ÇÐÀû Á¦Á¦ »ý»ê¿¡ ÇʼöÀûÀÌ¸ç ½ÃÀå ¼ºÀåÀ» ÁÖµµÇϰí ÀÖ½À´Ï´Ù.
ÀçÁ¶ÇÕ ¼¼Æ÷¹è¾ç º¸ÃæÁ¦ ½ÃÀå - ÁÖ¿ä ÀλçÀÌÆ®
´ç»çÀÇ ¸®¼Ä¡ ¾Ö³Î¸®½ºÆ®°¡ °øÀ¯ÇÑ ºÐ¼®¿¡ µû¸£¸é, ¼¼°è ½ÃÀåÀº ¿¹Ãø ±â°£(2024-2032) µ¿¾È ¸Å³â ¾à 7.39%ÀÇ CAGR·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.
À¯Çüº° ¼¼ºÐÈ¿¡ µû¸£¸é, ÀçÁ¶ÇÕ ¾ËºÎ¹Î ºÎ¹®Àº ¸¸¼º ÁúȯÀÇ À¯º´·ü Áõ°¡·Î ÀÎÇØ 2023³â¿¡ °¡Àå Å« ½ÃÀå Á¡À¯À²À» Â÷ÁöÇÒ °ÍÀ¸·Î ¿¹ÃøµÇ¾ú½À´Ï´Ù.
¿ëµµº°·Î´Â ¼¼Æ÷¹è¾ç ±â¼úÀÇ ¹ßÀüÀ¸·Î Áٱ⼼Æ÷ ¹× Àç»ýÀÇ·á ºÐ¾ß°¡ 2023³â ÁÖ¿ä ¿ëµµ·Î ²ÅÇû½À´Ï´Ù.
ÃÖÁ¾»ç¿ëÀÚ ¼¼ºÐȸ¦ ±âÁØÀ¸·Î º¼ ¶§, Á¦¾à ¹× »ý¸í°øÇÐ ±â¾÷ ºÎ¹®Àº 2023³â Á¦¾à ¹× »ý¸í°øÇÐ ±â¾÷ ºÎ¹®¿¡¼ »õ·Î¿î ¼¼Æ÷ ±â¹Ý Ä¡·á¹ýÀÇ Áõ°¡·Î ÀÎÇØ ÃÖÁ¾»ç¿ëÀÚ Áß °¡Àå Å« ºñÁßÀ» Â÷ÁöÇß½À´Ï´Ù.
Áö¿ªº°·Î´Â ºÏ¹Ì°¡ 2023³â ÁÖ¿ä ¼öÀÍ¿øÀ̾ú½À´Ï´Ù.
ÀçÁ¶ÇÕ ¼¼Æ÷¹è¾ç º¸ÃæÁ¦ ½ÃÀå - ¼¼ºÐÈ ºÐ¼®:
ÀçÁ¶ÇÕ ¼¼Æ÷¹è¾ç º¸ÃæÁ¦ ¼¼°è ½ÃÀåÀº À¯Çü, ¿ëµµ, ÃÖÁ¾»ç¿ëÀÚ ¹× Áö¿ª¿¡ µû¶ó ¼¼ºÐȵ˴ϴÙ.
ÀçÁ¶ÇÕ ¾ËºÎ¹Î, ÀçÁ¶ÇÕ Àν¶¸°, ÀçÁ¶ÇÕ Æ®·£½ºÆä¸°, ±âŸ. ÀçÁ¶ÇÕ ¾ËºÎ¹Î ºÎ¹®ÀÌ ½ÃÀåÀ» ÁÖµµÇϰí ÀÖ½À´Ï´Ù. ¸¸¼º Áúȯ°ú ¾Ï ÁúȯÀÇ À¯º´·ü Áõ°¡°¡ ½ÃÀå ¼ºÀåÀ» ÁÖµµÇϰí ÀÖ½À´Ï´Ù.
½ÃÀåÀº ¿ëµµº°·Î Áٱ⼼Æ÷-Àç»ýÀÇ·á, ¹ÙÀÌ¿À »ý»ê, ±âŸ ¼¼ °¡Áö·Î ºÐ·ùµË´Ï´Ù. Áٱ⼼Æ÷ ¹× Àç»ýÀÇ·á ºÐ¾ß°¡ ½ÃÀåÀ» ÁÖµµÇϰí ÀÖ½À´Ï´Ù. ¼¼Æ÷ Ä¡·á ¹× Àç»ýÀÇ·á ºÐ¾ßÀÇ °³¹ß È®´ë°¡ ÀÌ ºÎ¹®ÀÇ ¼ºÀåÀ» ÁÖµµÇϰí ÀÖ½À´Ï´Ù.
½ÃÀåÀº ÃÖÁ¾»ç¿ëÀÚº°·Î Á¦¾à ¹× ¹ÙÀÌ¿À ±â¾÷, ¿¬±¸±â°ü, ±âŸ ¼¼ °¡Áö·Î ºÐ·ùµË´Ï´Ù. Á¦¾à ¹× ¹ÙÀÌ¿À ±â¾÷ÀÌ ½ÃÀåÀ» µ¶Á¡Çϰí ÀÖÀ¸¸ç, ¿¹Ãø ±â°£ µ¿¾È ³ôÀº ¿ìÀ§¸¦ À¯ÁöÇÒ °ÍÀ¸·Î º¸ÀÔ´Ï´Ù. »ý¸í°øÇÐ ±â¾÷µéÀº »õ·Î¿î ¼¼Æ÷ Ä¡·áÁ¦¸¦ °³¹ßÇϱâ À§ÇØ Á¤ºÎ·ÎºÎÅÍ ¸¹Àº ÀÚ±ÝÀ» Áö¿ø¹ÞÀ¸¸ç ½ÃÀå¿¡¼ °æÀï·ÂÀ» À¯ÁöÇϰí ÀÖ½À´Ï´Ù.
ÀçÁ¶ÇÕ ¼¼Æ÷¹è¾ç º¸ÃæÁ¦ ½ÃÀå - Áö¸®Àû ÀλçÀÌÆ®
Áö¸®ÀûÀ¸·Î ÀÌ ½ÃÀåÀº ºÏ¹Ì, ¶óƾ¾Æ¸Þ¸®Ä«, À¯·´, ¾Æ½Ã¾ÆÅÂÆò¾ç, Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«¿¡ ºÐÆ÷µÇ¾î ÀÖ½À´Ï´Ù. ºÏ¹Ì, ƯÈ÷ ¹Ì±¹Àº ÀçÁ¶ÇÕ ¼¼Æ÷¹è¾ç º¸ÃæÁ¦ ¼¼°è ½ÃÀå¿¡¼ Áö¹èÀûÀÎ À§Ä¡¸¦ Â÷ÁöÇϰí ÀÖ½À´Ï´Ù. ¾ö°ÝÇÑ ±ÔÁ¦ ÇÁ·¹ÀÓ¿öÅ©¿Í °¡À̵å¶óÀÎÀÌ ¼¼Æ÷¹è¾ç ¹èÁö Á¦Á¦¿¡¼ µ¿¹°¼º ¼ººÐÀ» ÇÔÀ¯ÇÏÁö ¾ÊÀº °íǰÁú º¸ÃæÁ¦¿¡ ´ëÇÑ ¼ö¿ä¸¦ ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ÇÑÆí, À¯·´ ½ÃÀå¿¡¼´Â ¹ÙÀÌ¿À Á¦Á¶ÀÇ Àϰü¼º, ¾ÈÀü¼º ¹× ±ÔÁ¦ Áؼö¸¦ º¸ÀåÇϱâ À§ÇØ À¯ÀüÀÚÀçÁ¶ÇÕ º¸ÃæÁ¦ÀÇ »ç¿ëÀÌ °Á¶µÇ°í ÀÖ½À´Ï´Ù.
ÀçÁ¶ÇÕ ¼¼Æ÷¹è¾ç º¸ÃæÁ¦ ½ÃÀå - °æÀï »óȲ:
ÀçÁ¶ÇÕ ¼¼Æ÷¹è¾ç º¸ÃæÁ¦ ½ÃÀåÀº »õ·Î¿î ¼¼Æ÷ Ä¡·áÁ¦ Çõ½ÅÀ» À§ÇØ Áö¼ÓÀûÀ¸·Î ³ë·ÂÇÏ´Â ¿©·¯ ÁÖ¿ä ±â¾÷µéÀÌ Ä¡¿ÇÑ °æÀïÀ» ¹úÀ̰í ÀÖ½À´Ï´Ù. ½ÃÀå ÁøÀÔ ±â¾÷µéÀº Àü¹® Áö½ÄÀ» Ȱ¿ëÇÏ°í ½ÃÀå µµ´Þ ¹üÀ§¸¦ È®´ëÇϱâ À§ÇØ Çаè, »ý¸í°øÇÐ ±â¾÷, Á¦¾à»ç¿ÍÀÇ Á¦ÈÞ ¹× °øµ¿ ¿¬±¸¸¦ Àû±ØÀûÀ¸·Î ÃßÁøÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ¹ÙÀÌ¿ÀÀǾàǰ Á¦Á¶ Ȱµ¿ÀÇ È®´ë¿¡ ´ëÀÀÇϱâ À§ÇØ ±â¾÷µéÀº ƯÈ÷ ¾Æ½Ã¾ÆÅÂÆò¾ç ¹× ¶óƾ¾Æ¸Þ¸®Ä« µî ½ÅÈï ½ÃÀå¿¡¼ Áö¸®Àû ÀÔÁö¸¦ È®ÀåÇϰí ÀÖ½À´Ï´Ù.
¸ñÂ÷
Á¦1Àå ÀçÁ¶ÇÕ ¼¼Æ÷¹è¾ç º¸ÃæÁ¦ ½ÃÀå °³¿ä
Á¦2Àå ÁÖ¿ä ¿ä¾à
Á¦3Àå ÀçÁ¶ÇÕ ¼¼Æ÷¹è¾ç º¸ÃæÁ¦ÀÇ ÁÖ¿ä ½ÃÀå µ¿Çâ
½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ
½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ
½ÃÀå ±âȸ
½ÃÀå Àü¸Á µ¿Çâ
Á¦4Àå ÀçÁ¶ÇÕ ¼¼Æ÷¹è¾ç º¸ÃæÁ¦ »ê¾÷ ¿¬±¸
PEST ºÐ¼®
Porter's Five Forces ºÐ¼®
¼ºÀå Àü¸Á ¸ÅÇÎ
±ÔÁ¦ ÇÁ·¹ÀÓ¿öÅ© ºÐ¼®
Á¦5Àå ÀçÁ¶ÇÕ ¼¼Æ÷¹è¾ç º¸ÃæÁ¦ ½ÃÀå : COVID-19ÀÇ ¿µÇ⠺м®
COVID-19 ÀÌÀüÀÇ ¿µÇ⠺м®
COVID-19 ÀÌÈÄÀÇ ¿µÇ⠺м®
Á¦6Àå ÀçÁ¶ÇÕ ¼¼Æ÷¹è¾ç º¸ÃæÁ¦ ½ÃÀå »óȲ
ÀçÁ¶ÇÕ ¼¼Æ÷¹è¾ç º¸ÃæÁ¦ ½ÃÀå Á¡À¯À² ºÐ¼®, 2023³â
ÁÖ¿ä Á¦Á¶¾÷üº° ³»¿ª µ¥ÀÌÅÍ
±âÁ¸ ±â¾÷ ºÐ¼®
½ÅÈï ±â¾÷ ºÐ¼®
Á¦7Àå ÀçÁ¶ÇÕ ¼¼Æ÷¹è¾ç º¸ÃæÁ¦ ½ÃÀå - À¯Çüº°
°³¿ä
ºÎ¹® Á¡À¯À² ºÐ¼®(À¯Çüº°)
ÀçÁ¶ÇÕ ¾ËºÎ¹Î
ÀçÁ¶ÇÕ Àν¶¸°
ÀçÁ¶ÇÕ Æ®·£½ºÆä¸°
±âŸ
Á¦8Àå ÀçÁ¶ÇÕ ¼¼Æ÷¹è¾ç º¸ÃæÁ¦ ½ÃÀå - ¿ëµµº°
°³¿ä
¿ëµµº° ºÎ¹® Á¡À¯À² ºÐ¼®
Áٱ⼼Æ÷¿Í Àç»ýÀÇ·á
¹ÙÀÌ¿À ÇÁ·Î´ö¼Ç
±âŸ
Á¦9Àå ÀçÁ¶ÇÕ ¼¼Æ÷¹è¾ç º¸ÃæÁ¦ ½ÃÀå - ÃÖÁ¾»ç¿ëÀÚº°
°³¿ä
ÃÖÁ¾»ç¿ëÀÚº° ºÎ¹® Á¡À¯À² ºÐ¼®
Á¦¾à¡¤¹ÙÀÌ¿ÀÅ×Å©³î·¯Áö ±â¾÷
¿¬±¸±â°ü
±âŸ
Á¦10Àå ÀçÁ¶ÇÕ ¼¼Æ÷¹è¾ç º¸ÃæÁ¦ ½ÃÀå - Áö¿ªº°
¼Ò°³
ºÏ¹Ì
°³¿ä
ºÏ¹ÌÀÇ ÁÖ¿ä Á¦Á¶¾÷ü
¹Ì±¹
ij³ª´Ù
À¯·´
°³¿ä
À¯·´ÀÇ ÁÖ¿ä Á¦Á¶¾÷ü
µ¶ÀÏ
ÀÌÅ»¸®¾Æ
¿µ±¹
ÇÁ¶û½º
·¯½Ã¾Æ
³×´ú¶õµå
½º¿þµ§
Æú¶õµå
±âŸ
¾Æ½Ã¾ÆÅÂÆò¾ç(APAC)
°³¿ä
¾Æ½Ã¾ÆÅÂÆò¾çÀÇ ÁÖ¿ä Á¦Á¶¾÷ü
Àεµ
Áß±¹
ÀϺ»
Çѱ¹
È£ÁÖ
ű¹
Àεµ³×½Ã¾Æ
Çʸ®ÇÉ
±âŸ
¶óƾ¾Æ¸Þ¸®Ä«
°³¿ä
¶óƾ¾Æ¸Þ¸®Ä«ÀÇ ÁÖ¿ä Á¦Á¶¾÷ü
ºê¶óÁú
¸ß½ÃÄÚ
¾Æ¸£ÇîÆ¼³ª
ÄÝ·Òºñ¾Æ
±âŸ
Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
°³¿ä
Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«ÀÇ ÁÖ¿ä Á¦Á¶¾÷ü
»ç¿ìµð¾Æ¶óºñ¾Æ
¾Æ¶ø¿¡¹Ì¸®Æ®
À̽º¶ó¿¤
ÅÍŰ
¾ËÁ¦¸®
ÀÌÁýÆ®
±âŸ
Á¦11Àå ÁÖ¿ä º¥´õ ºÐ¼® - ÀçÁ¶ÇÕ ¼¼Æ÷¹è¾ç º¸ÃæÁ¦ ¾÷°è
°æÀï ´ë½Ãº¸µå
±â¾÷ °³¿ä
Thermo Fisher Scientific
Merck KGaA
Lonza Group
GE Healthcare Life Sciences
STEMCELL Technologies
Corning Life Sciences
BD Biosciences
Fujifilm Irvine Scientific
Sartorius AG
Bio-Techne Corporation
PeproTech
Biological Industries
Gibco
CellGenix
Repligen Corporation
Others
Á¦12Àå ¾Ö³Î¸®½ºÆ®ÀÇ Àü¹æÀ§ Àü¸Á
ksm
REPORT HIGHLIGHT
Recombinant Cell Culture Supplements Market size was valued at USD 2,702.32 Million in 2023, expanding at a CAGR of 7.39% from 2024 to 2032.
Recombinant cell culture supplements are added to cell culture media to support the growth, viability, and productivity of cells in vitro application. These supplements are typically derived from recombinant sources, meaning they are produced using genetic engineering techniques in host organisms like bacteria, yeast, or mammalian cells.
Recombinant Cell Culture Supplements Market- Market Dynamics
Growing demand from biopharmaceuticals and research in stem therapies are expected to propel market demand
The biopharmaceutical sector continues to expand, driven by the development of biologics such as monoclonal antibodies, vaccines, and cell therapies. Recombinant cell culture supplements are essential to produce these biologics in large-scale cell culture systems. Thus, high demand for cell culture supplements from the biopharmaceutical industry is projected to bolster market growth. Technological innovations in cell culture techniques, such as perfusion systems, single-use bioreactors, and microcarrier-based cultures, require specialized media formulations with precise compositions of recombinant supplements to optimize cell growth and productivity.
Further, the field of regenerative medicine and stem cell therapies is expanding rapidly, driving the demand for advanced cell culture systems that support the growth and differentiation of stem cells. Recombinant supplements play a critical role in providing the necessary growth factors and cytokines for these applications. The prevalence of chronic diseases such as cancer, diabetes, and autoimmune disorders is rising globally, prompting pharmaceutical companies to develop new therapies. Recombinant cell culture supplements are essential to produce biologics used in these therapies, driving market growth.
Recombinant Cell Culture Supplements Market- Key Insights
As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 7.39% over the forecast period (2024-2032)
Based on Type segmentation, recombinant albumin segment was predicted to show maximum market share in the year 2023, owing to growing prevalence of chronic diseases.
Based on Application segmentation, the stem cell & regenerative medicine segment was the leading Application in 2023, due to rising advancements in cell culture technology.
Based on End User segmentation, pharmaceutical & biotech companies' segment was the leading End User in 2023, owing to increasing number of novel cell-based therapies in biotech companies.
On the basis of region, North America was the leading revenue generator in 2023, owing to rising government funding in cell technology.
Recombinant Cell Culture Supplements Market- Segmentation Analysis:
The Global Recombinant Cell Culture Supplements Market is segmented on the basis of Type, Application, End User, and Region.
The market is divided into four categories based on Type: recombinant albumin, recombinant insulin, recombinant transferrin, and others. The recombinant albumin segment dominates the market. The growing prevalence of chronic and cancer disorders is boosting market growth.
The market is divided into three categories based on Application: stem cell & regenerative medicine, bioproduction, and others. The stem cell & regenerative medicine segment dominates the market. Growing developments in cell therapies and regenerative medicine are mainly spurring segment growth.
The market is divided into three categories based on End User: pharmaceutical & biotech companies, research institutes, and others. The pharmaceutical & biotech companies segment dominates the market and is expected to maintain its high dominance during the forecast period. Biotech companies attract significant government funding to advance novel cell therapies to remain competent in the market.
Recombinant Cell Culture Supplements Market- Geographical Insights
Geographically, this market is widespread in the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. North America, specifically the United States, holds a dominant position in the global market for recombinant cell culture supplements. Stringent regulatory frameworks and guidelines drive the demand for high-quality, animal component-free supplements in cell culture media formulations. On the other side, European markets emphasize the use of recombinant supplements to ensure consistency, safety, and regulatory compliance in biomanufacturing.
Recombinant Cell Culture Supplements Market- Competitive Landscape:
The Recombinant Cell Culture Supplements market is characterized by intense competition among several key players who are continuously striving to innovate new cell therapies. Market players indulge in partnerships, collaborations with academic institutions, biotech companies, and pharmaceutical firms are common to leverage expertise and expand market reach. Further, companies are expanding their geographical presence, particularly in emerging markets like Asia-Pacific and Latin America, to capitalize on growing biopharmaceutical manufacturing activities.
Recent Developments:
In 2023, Lonza, a prominent supplier of cell culture solutions, has partnered with Sartorius, a leading provider of equipment and services for the biopharmaceutical industry.
In 2023, Thermo Fisher Scientific Inc. has collaborated with Cell and Gene Therapy Catapult, an innovation center in the UK focused on advancing cell and gene therapies.
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET KEY PLAYERS
Thermo Fisher Scientific
Merck KGaA
Lonza Group
GE Healthcare Life Sciences
STEMCELL Technologies
Corning Life Sciences
BD Biosciences
Fujifilm Irvine Scientific
Sartorius AG
Bio-Techne Corporation
PeproTech
Biological Industries
Gibco
CellGenix
Repligen Corporation
Others
GLOBAL RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET, BY TYPE- MARKET ANALYSIS, 2019-2032
Recombinant albumin
Recombinant insulin
Recombinant transferrin
Others
GLOBAL RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET, BY APPLICATION- MARKET ANALYSIS, 2019-2032
Stem cell & regenerative medicine
Bioproduction
Others
GLOBAL RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET, BY END USER- MARKET ANALYSIS, 2019-2032
Pharmaceutical & biotech companies
Research institutes
Others
GLOBAL RECOMBINANT CELL CULTURE SUPPLEMENTS MARKET, BY REGION- MARKET ANALYSIS, 2019-2032
North America
The U.S.
Canada
Europe
Germany
France
Italy
Spain
United Kingdom
Russia
Netherlands
Sweden
Poland
Rest of Europe
Asia Pacific
India
China
South Korea
Japan
Australia
Thailand
Indonesia
Philippines
Rest of APAC
Latin America
Brazil
Mexico
Argentina
Colombia
Rest of LATAM
The Middle East and Africa
Saudi Arabia
United Arab Emirates
Israel
Turkey
Algeria
Egypt
Rest of MEA
Table of Contents
1. Recombinant Cell Culture Supplements Market Overview
1.1. Study Scope
1.2. Market Estimation Years
2. Executive Summary
2.1. Market Snippet
2.1.1. Recombinant Cell Culture Supplements Market Snippet by Type
2.1.2. Recombinant Cell Culture Supplements Market Snippet by Application
2.1.3. Recombinant Cell Culture Supplements Market Snippet by End User
2.1.4. Recombinant Cell Culture Supplements Market Snippet by Country
2.1.5. Recombinant Cell Culture Supplements Market Snippet by Region
2.2. Competitive Insights
3. Recombinant Cell Culture Supplements Key Market Trends
3.1. Recombinant Cell Culture Supplements Market Drivers
3.1.1. Impact Analysis of Market Drivers
3.2. Recombinant Cell Culture Supplements Market Restraints
3.2.1. Impact Analysis of Market Restraints
3.3. Recombinant Cell Culture Supplements Market Opportunities
3.4. Recombinant Cell Culture Supplements Market Future Trends
4. Recombinant Cell Culture Supplements Industry Study
4.1. PEST Analysis
4.2. Porter's Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis
5. Recombinant Cell Culture Supplements Market: COVID-19 Impact Analysis
5.1. Pre-COVID-19 Impact Analysis
5.2. Post-COVID-19 Impact Analysis
5.2.1. Top Performing Segments
5.2.2. Marginal Growth Segments
5.2.3. Top Looser Segments
5.2.4. Marginal Loss Segments
6. Recombinant Cell Culture Supplements Market Landscape
6.1. Recombinant Cell Culture Supplements Market Share Analysis, 2023
6.2. Breakdown Data, by Key Manufacturer
6.2.1. Established Players' Analysis
6.2.2. Emerging Players' Analysis
7. Recombinant Cell Culture Supplements Market - By Type
7.1. Overview
7.1.1. Segment Share Analysis, By Type, 2024 & 2032 (%)
7.1.2. Recombinant albumin
7.1.3. Recombinant insulin
7.1.4. Recombinant transferrin
7.1.5. Others
8. Recombinant Cell Culture Supplements Market - By Application
8.1. Overview
8.1.1. Segment Share Analysis, By Application, 2024 & 2032 (%)
8.1.2. Stem cell & regenerative medicine
8.1.3. Bioproduction
8.1.4. Others
9. Recombinant Cell Culture Supplements Market - By End User
9.1. Overview
9.1.1. Segment Share Analysis, By End User, 2024 & 2032 (%)
9.1.2. Pharmaceutical & biotech companies
9.1.3. Research institutes
9.1.4. Others
10. Recombinant Cell Culture Supplements Market- By Geography
10.1. Introduction
10.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
10.2. North America
10.2.1. Overview
10.2.2. Recombinant Cell Culture Supplements Key Manufacturers in North America
10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
10.2.4. North America Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
10.2.5. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.2.6. North America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.2.7. U.S.
10.2.7.1. Overview
10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.2.7.3. U.S. Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
10.2.7.4. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.2.7.5. U.S. Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.2.8. Canada
10.2.8.1. Overview
10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.2.8.3. Canada Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
10.2.8.4. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.2.8.5. Canada Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.3. Europe
10.3.1. Overview
10.3.2. Recombinant Cell Culture Supplements Key Manufacturers in Europe
10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
10.3.4. Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
10.3.5. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.3.6. Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.3.7. Germany
10.3.7.1. Overview
10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.7.3. Germany Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
10.3.7.4. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.3.7.5. Germany Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.3.8. Italy
10.3.8.1. Overview
10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.8.3. Italy Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
10.3.8.4. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.3.8.5. Italy Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.3.9. United Kingdom
10.3.9.1. Overview
10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.9.3. United Kingdom Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
10.3.9.4. United Kingdom Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.3.9.5. United Kingdom Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.3.10. France
10.3.10.1. Overview
10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.10.3. France Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
10.3.10.4. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.3.10.5. France Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.3.11. Russia
10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.11.2. Russia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
10.3.11.3. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.3.11.4. Russia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.3.12. Netherlands
10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.12.2. Netherlands Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
10.3.12.3. Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.3.12.4. Netherlands Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.3.13. Sweden
10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.13.2. Sweden Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
10.3.13.3. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.3.13.4. Sweden Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.3.14. Poland
10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.14.2. Poland Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
10.3.14.3. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.3.14.4. Poland Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.3.15. Rest of Europe
10.3.15.1. Overview
10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.15.3. Rest of the Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
10.3.15.4. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.3.15.5. Rest of the Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.4. Asia Pacific (APAC)
10.4.1. Overview
10.4.2. Recombinant Cell Culture Supplements Key Manufacturers in Asia Pacific
10.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
10.4.4. Asia Pacific Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
10.4.5. Asia Pacific Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.4.6. Asia Pacific Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.4.7. India
10.4.7.1. Overview
10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.7.3. India Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
10.4.7.4. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.4.7.5. India Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.4.8. China
10.4.8.1. Overview
10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.8.3. China Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
10.4.8.4. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.4.8.5. China Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.4.9. Japan
10.4.9.1. Overview
10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.9.3. Japan Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
10.4.9.4. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.4.9.5. Japan Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.4.10. South Korea
10.4.10.1. Overview
10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.10.3. South Korea Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
10.4.10.4. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.4.10.5. South Korea Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.4.11. Australia
10.4.11.1. Overview
10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.11.3. Australia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
10.4.11.4. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.4.11.5. Australia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.4.12. Thailand
10.4.12.1. Overview
10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.12.3. Thailand Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
10.4.12.4. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.4.12.5. Thailand Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.4.13. Indonesia
10.4.13.1. Overview
10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.13.3. Indonesia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
10.4.13.4. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.4.13.5. Indonesia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.4.14. Philippines
10.4.14.1. Overview
10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.14.3. Philippines Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
10.4.14.4. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.4.14.5. Philippines Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.4.15. Rest of APAC
10.4.15.1. Overview
10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.15.3. Rest of APAC Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
10.4.15.4. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.4.15.5. Rest of APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.5. Latin America
10.5.1. Overview
10.5.2. Recombinant Cell Culture Supplements Key Manufacturers in Latin America
10.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
10.5.4. Latin America Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
10.5.5. Latin America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.5.6. Latin America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.5.7. Brazil
10.5.7.1. Overview
10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.5.7.3. Brazil Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
10.5.7.4. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.5.7.5. Brazil Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.5.8. Mexico
10.5.8.1. Overview
10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.5.8.3. Mexico Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
10.5.8.4. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.5.8.5. Mexico Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.5.9. Argentina
10.5.9.1. Overview
10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.5.9.3. Argentina Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
10.5.9.4. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.5.9.5. Argentina Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.5.10. Colombia
10.5.10.1. Overview
10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.5.10.3. Colombia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
10.5.10.4. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.5.10.5. Colombia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.5.11. Rest of LATAM
10.5.11.1. Overview
10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.5.11.3. Rest of LATAM Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
10.5.11.4. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.5.11.5. Rest of LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.6. Middle East and Africa
10.6.1. Overview
10.6.2. Recombinant Cell Culture Supplements Key Manufacturers in Middle East and Africa
10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
10.6.4. Middle East and Africa Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
10.6.5. Middle East and Africa Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.6.6. Middle East and Africa Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.6.7. Saudi Arabia
10.6.7.1. Overview
10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.6.7.3. Saudi Arabia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
10.6.7.4. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.6.7.5. Saudi Arabia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.6.8. United Arab Emirates
10.6.8.1. Overview
10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.6.8.3. United Arab Emirates Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
10.6.8.4. United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.6.8.5. United Arab Emirates Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.6.9. Israel
10.6.9.1. Overview
10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.6.9.3. Israel Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
10.6.9.4. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.6.9.5. Israel Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.6.10. Turkey
10.6.10.1. Overview
10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.6.10.3. Turkey Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
10.6.10.4. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.6.10.5. Turkey Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.6.11. Algeria
10.6.11.1. Overview
10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.6.11.3. Algeria Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
10.6.11.4. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.6.11.5. Algeria Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.6.12. Egypt
10.6.12.1. Overview
10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.6.12.3. Egypt Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
10.6.12.4. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.6.12.5. Egypt Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.6.13. Rest of MEA
10.6.13.1. Overview
10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.6.13.3. Rest of MEA Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
10.6.13.4. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.6.13.5. Rest of MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11. Key Vendor Analysis- Recombinant Cell Culture Supplements Industry
11.1. Competitive Dashboard
11.2. Company Profiles
11.2.1. Thermo Fisher Scientific
11.2.2. Merck KGaA
11.2.3. Lonza Group
11.2.4. GE Healthcare Life Sciences
11.2.5. STEMCELL Technologies
11.2.6. Corning Life Sciences
11.2.7. BD Biosciences
11.2.8. Fujifilm Irvine Scientific
11.2.9. Sartorius AG
11.2.10. Bio-Techne Corporation
11.2.11. PeproTech
11.2.12. Biological Industries
11.2.13. Gibco
11.2.14. CellGenix
11.2.15. Repligen Corporation
11.2.16. Others
12. 360 Degree Analyst View
13. Appendix
13.1. Research Methodology
13.2. References
13.3. Abbreviations
13.4. Disclaimer
13.5. Contact Us